Krześlak A - Search Results

1

Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.

Krześlak A, Forma E, Chwatko G, Jóźwiak P, Szymczyk A, Wilkosz J, Różański W, Bryś M. Krześlak A, et al. Toxicol Appl Pharmacol. 2013 May 1;268(3):278-85. doi: 10.1016/j.taap.2013.02.013. Epub 2013 Mar 4. Toxicol Appl Pharmacol. 2013. PMID: 23466427

2

Gene expression of O-GlcNAc cycling enzymes in human breast cancers.

Krześlak A, Forma E, Bernaciak M, Romanowicz H, Bryś M. Krześlak A, et al. Clin Exp Med. 2012 Mar;12(1):61-5. doi: 10.1007/s10238-011-0138-5. Epub 2011 May 13. Clin Exp Med. 2012. PMID: 21567137 Free PMC article.

3

Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.

Krześlak A, Jóźwiak P, Lipińska A. Krześlak A, et al. Oncol Rep. 2011 Sep;26(3):743-9. doi: 10.3892/or.2011.1333. Epub 2011 May 31. Oncol Rep. 2011. PMID: 21637923

4

Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.

Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M. Krzeslak A, et al. Pathol Oncol Res. 2012 Jul;18(3):721-8. doi: 10.1007/s12253-012-9500-5. Epub 2012 Jan 21. Pathol Oncol Res. 2012. PMID: 22270867 Free PMC article.

5

Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations.

Krześlak A, Wójcik-Krowiranda K, Forma E, Bieńkiewicz A, Bryś M. Krześlak A, et al. Ginekol Pol. 2012 Jan;83(1):22-6. Ginekol Pol. 2012. PMID: 22384635

6

Expression of TopBP1 in hereditary breast cancer.

Forma E, Krzeslak A, Bernaciak M, Romanowicz-Makowska H, Brys M. Forma E, et al. Among authors: krzeslak a. Mol Biol Rep. 2012 Jul;39(7):7795-804. doi: 10.1007/s11033-012-1622-z. Epub 2012 Apr 28. Mol Biol Rep. 2012. PMID: 22544570 Free PMC article.

7

Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions.

Jóźwiak P, Krześlak A, Pomorski L, Lipińska A. Jóźwiak P, et al. Among authors: krzeslak a. Mol Med Rep. 2012 Sep;6(3):601-6. doi: 10.3892/mmr.2012.969. Epub 2012 Jun 27. Mol Med Rep. 2012. PMID: 22752218

8

Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level.

Rozanski W, Krzeslak A, Forma E, Brys M, Blewniewski M, Wozniak P, Lipinski M. Rozanski W, et al. Among authors: krzeslak a. Clin Lab. 2012;58(5-6):579-83. Clin Lab. 2012. PMID: 22783592

9

Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.

Forma E, Krzeslak A, Wilkosz J, Jozwiak P, Szymczyk A, Rozanski W, Brys M. Forma E, et al. Among authors: krzeslak a. Cancer Genet. 2012 Sep;205(9):432-5. doi: 10.1016/j.cancergen.2012.05.005. Epub 2012 Jul 21. Cancer Genet. 2012. PMID: 22824183

10

Relationship of urinary isoprostanes to prostate cancer occurrence.

Brys M, Morel A, Forma E, Krzeslak A, Wilkosz J, Rozanski W, Olas B. Brys M, et al. Among authors: krzeslak a. Mol Cell Biochem. 2013 Jan;372(1-2):149-53. doi: 10.1007/s11010-012-1455-z. Epub 2012 Sep 16. Mol Cell Biochem. 2013. PMID: 22983829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters